$SCYX
SCYNEXIS INC

2021 Q2 Form 10-Q Financial Statement

#000156459021044448 Filed on August 16, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.77M $3.357M $2.613M
YoY Change 280.52% 20.8% 16.6%
% of Gross Profit
Research & Development $4.734M $8.469M $9.866M
YoY Change -44.1% -0.06% 1.88%
% of Gross Profit
Depreciation & Amortization $55.00K $20.00K $28.00K
YoY Change 175.0% -33.33% -3.45%
% of Gross Profit
Operating Expenses $17.51M $11.83M $12.48M
YoY Change 48.05% 5.09% 4.65%
Operating Profit -$17.51M -$11.83M -$12.48M
YoY Change 48.05% 5.63% 5.21%
Interest Expense $445.0K $319.0K $210.0K
YoY Change 39.5% 52.63% -42.78%
% of Operating Profit
Other Income/Expense, Net $15.03M $2.301M $5.477M
YoY Change 553.11% -17.62% -149.58%
Pretax Income -$2.480M -$9.525M -$7.000M
YoY Change -73.96% 13.35% -69.45%
Income Tax -$4.138M -$3.144M
% Of Pretax Income
Net Earnings $1.658M -$6.381M -$7.002M
YoY Change -125.98% -24.06% -69.43%
Net Earnings / Revenue
Basic Earnings Per Share $0.06 -$0.64 -$0.72
Diluted Earnings Per Share -$0.22 -$0.64 -$0.72
COMMON SHARES
Basic Shares Outstanding 26.02M 10.01M 9.745M
Diluted Shares Outstanding 26.49M 10.01M 9.745M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.4M $37.60M $34.50M
YoY Change 199.06% 6.82% -11.76%
Cash & Equivalents $112.4M $34.00M $20.53M
Short-Term Investments $3.600M $14.30M
Other Short-Term Assets $369.0K $863.0K $914.0K
YoY Change -57.24% 1469.09% 1561.82%
Inventory $92.00K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $115.6M $40.57M $36.80M
YoY Change 185.04% 12.24% -8.23%
LONG-TERM ASSETS
Property, Plant & Equipment $3.118M $354.0K $3.500M
YoY Change 780.79% -23.04% -7.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.810M $812.0K $1.200M
YoY Change 122.91% 0.0% 0.0%
Total Long-Term Assets $5.500M $4.700M $4.700M
YoY Change 17.02% -4.68% -5.38%
TOTAL ASSETS
Total Short-Term Assets $115.6M $40.57M $36.80M
Total Long-Term Assets $5.500M $4.700M $4.700M
Total Assets $121.1M $45.27M $41.50M
YoY Change 167.59% 10.21% -7.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.946M $4.853M $5.200M
YoY Change 22.52% 27.51% 121.65%
Accrued Expenses $3.374M $2.387M $1.800M
YoY Change 41.35% -30.08% -18.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $19.88M $7.316M $7.100M
YoY Change 171.72% 0.94% 54.35%
LONG-TERM LIABILITIES
Long-Term Debt $40.37M $18.30M $11.10M
YoY Change 120.61%
Other Long-Term Liabilities $28.56M $13.40M $16.90M
YoY Change 113.13% 52.27% 56.48%
Total Long-Term Liabilities $68.93M $31.70M $28.00M
YoY Change 117.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.88M $7.316M $7.100M
Total Long-Term Liabilities $68.93M $31.70M $28.00M
Total Liabilities $88.81M $38.93M $35.05M
YoY Change 128.11% 437.17% 3.9%
SHAREHOLDERS EQUITY
Retained Earnings -$329.6M -$284.8M -$278.4M
YoY Change 15.73% 15.71%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.32M $6.333M $6.455M
YoY Change
Total Liabilities & Shareholders Equity $121.1M $45.27M $41.51M
YoY Change 167.59% 10.14% -7.89%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $1.658M -$6.381M -$7.002M
YoY Change -125.98% -24.06% -69.43%
Depreciation, Depletion And Amortization $55.00K $20.00K $28.00K
YoY Change 175.0% -33.33% -3.45%
Cash From Operating Activities -$11.69M -$8.850M -$14.06M
YoY Change 32.14% 14.05% 116.23%
INVESTING ACTIVITIES
Capital Expenditures -$51.00K $0.00 $4.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $10.67M -$7.760M
YoY Change -100.0% 6.49% -217.58%
Cash From Investing Activities -$51.00K $10.66M -$7.762M
YoY Change -100.48% 6.39% -217.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $214.0K
YoY Change -91.73%
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities 32.18M 11.96M 152.0K
YoY Change 169.06% 204.33% -89.26%
NET CHANGE
Cash From Operating Activities -11.69M -8.850M -14.06M
Cash From Investing Activities -51.00K 10.66M -7.762M
Cash From Financing Activities 32.18M 11.96M 152.0K
Net Change In Cash 20.43M 13.77M -21.67M
YoY Change 48.4% 122.46% -1533.95%
FREE CASH FLOW
Cash From Operating Activities -$11.69M -$8.850M -$14.06M
Capital Expenditures -$51.00K $0.00 $4.000K
Free Cash Flow -$11.64M -$8.850M -$14.06M
YoY Change 31.56% 14.05% 116.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y1M2D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M2D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M15D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y9M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y4M13D
CY2021Q2 us-gaap Inventory Net
InventoryNet
92000
CY2020Q4 us-gaap Inventory Net
InventoryNet
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16567000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8329000
CY2021Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
462000
CY2020Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
693000
us-gaap Operating Expenses
OperatingExpenses
31150000
us-gaap Operating Expenses
OperatingExpenses
24301000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11826000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
18000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
73000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
10000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34294000
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
321000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
525000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12050000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8469000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11682000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18335000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3357000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19468000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5966000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
11826000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19100000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24301000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-806000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-806000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
599000
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
36000
us-gaap Interest Income Other
InterestIncomeOther
12000
us-gaap Interest Income Other
InterestIncomeOther
183000
CY2020Q2 us-gaap Interest Expense
InterestExpense
319000
us-gaap Interest Expense
InterestExpense
659000
us-gaap Interest Expense
InterestExpense
529000
CY2021Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000
CY2020Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
60000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
405000
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
602000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
602000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15271000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3560000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
372000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1393000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15028000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2301000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13044000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7774000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2480000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9525000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6056000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16527000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4138000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3144000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3038000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3144000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1658000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6381000
us-gaap Net Income Loss
NetIncomeLoss
-3018000
us-gaap Net Income Loss
NetIncomeLoss
-13383000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.35
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26015292
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10009614
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25909457
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9877094
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26487973
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10009614
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26505808
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9877094
us-gaap Profit Loss
ProfitLoss
-3018000
us-gaap Profit Loss
ProfitLoss
-13383000
us-gaap Depreciation
Depreciation
85000
us-gaap Depreciation
Depreciation
54000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
940000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
821000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
0
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
23000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
525000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
599000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16567000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8329000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
372000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1393000
scyx Noncash Operating Lease Expenses For Right Of Use Asset
NoncashOperatingLeaseExpensesForRightOfUseAsset
100000
scyx Noncash Operating Lease Expenses For Right Of Use Asset
NoncashOperatingLeaseExpensesForRightOfUseAsset
97000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-806000
scyx Noncash Consideration Associated With Common Stock Purchase Agreement
NoncashConsiderationAssociatedWithCommonStockPurchaseAgreement
0
scyx Noncash Consideration Associated With Common Stock Purchase Agreement
NoncashConsiderationAssociatedWithCommonStockPurchaseAgreement
602000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1914000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1069000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1214000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3833000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12454000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22913000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
17142000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
251000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
14235000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-251000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2903000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3431000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2751000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
78000
scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
123000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
30000000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
1253000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
0
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
9000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
462000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32109000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12111000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
19404000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7899000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93314000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42193000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112718000
us-gaap Interest Paid Net
InterestPaidNet
511000
us-gaap Interest Paid Net
InterestPaidNet
420000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
11000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
173000
us-gaap Stock Issued1
StockIssued1
7452000
us-gaap Stock Issued1
StockIssued1
2784000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
321000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
0
scyx Deferred Offering Costs Incurred But Not Yet Paid
DeferredOfferingCostsIncurredButNotYetPaid
106000
scyx Common Stock Issued For Commitment Shares
CommonStockIssuedForCommitmentShares
0
scyx Common Stock Issued For Commitment Shares
CommonStockIssuedForCommitmentShares
602000
scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
298000
scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
0
scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
390000
scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
0
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-329600000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112400000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1658000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6381000
us-gaap Net Income Loss
NetIncomeLoss
-3018000
us-gaap Net Income Loss
NetIncomeLoss
-13383000
CY2021Q2 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-7415000
CY2020Q2 scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
-8739000
scyx Dilutive Securities Effect On Basic Earnings Per Share Warrant Liability
DilutiveSecuritiesEffectOnBasicEarningsPerShareWarrantLiability
0
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5757000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6381000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11757000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13383000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26015292
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10009614
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25909457
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9877094
CY2021Q2 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
472681
CY2020Q2 scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
596351
scyx Incremental Common Shares Attributable To Warrant Liabilities
IncrementalCommonSharesAttributableToWarrantLiabilities
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26505808
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9877094
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15133722
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9332077
CY2021Q2 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
1428000
CY2020Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
1535000
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
761000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
362000
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
481000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
19000
CY2021Q2 us-gaap Other Receivables
OtherReceivables
0
CY2020Q4 us-gaap Other Receivables
OtherReceivables
2876000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
369000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
373000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3039000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5165000
CY2021Q2 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1045000
CY2020Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
991000
CY2021Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
935000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2190000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1394000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
960000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3374000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4141000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20737000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9263000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2021Q2 scyx Debt Instrument Final Fee Due At Maturity
DebtInstrumentFinalFeeDueAtMaturity
1185000
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
31185000
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2809000
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
28376000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which was reduced by fifty-five thousand dollars on the first anniversary of the commencement date.  The security deposit will continue to be reduced by fifty-five thousand dollars every two years on the commencement date anniversary for eight years.
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
us-gaap Operating Lease Cost
OperatingLeaseCost
332000
us-gaap Operating Lease Cost
OperatingLeaseCost
332000
CY2021Q2 scyx Variable Lease Cost And Income
VariableLeaseCostAndIncome
10000
CY2020Q2 scyx Variable Lease Cost And Income
VariableLeaseCostAndIncome
6000
scyx Variable Lease Cost And Income
VariableLeaseCostAndIncome
9000
scyx Variable Lease Cost And Income
VariableLeaseCostAndIncome
27000
CY2021Q2 us-gaap Lease Cost
LeaseCost
176000
CY2020Q2 us-gaap Lease Cost
LeaseCost
172000
us-gaap Lease Cost
LeaseCost
341000
us-gaap Lease Cost
LeaseCost
359000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
57000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
56000
us-gaap Operating Lease Payments
OperatingLeasePayments
227000
us-gaap Operating Lease Payments
OperatingLeasePayments
223000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
290000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
527000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
715000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
730000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
744000
CY2021Q2 scyx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2789000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5795000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3330000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
60000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3270000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3330000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2465000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23147552
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23147552
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19663698
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19663698
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
25924000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1658000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
542000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3415000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
766000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
32320000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22758000
us-gaap Net Income Loss
NetIncomeLoss
-3018000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
940000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3412000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
766000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
32320000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
6455000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
410000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2463000
CY2020Q2 scyx Stock Issued During Period Value Commitment Shares
StockIssuedDuringPeriodValueCommitmentShares
602000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6333000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12895000
us-gaap Net Income Loss
NetIncomeLoss
-13383000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
821000
scyx Stock Issued During Period Value Employee Stock Purchase Plan And Stock Option Plans
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanAndStockOptionPlans
18000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2669000
scyx Stock Issued During Period Value Commitment Shares
StockIssuedDuringPeriodValueCommitmentShares
602000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-73000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6333000
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
25249113
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
28028978
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15300000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3600000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-16600000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8300000
CY2021Q2 scyx Fair Value Of Liabilities
FairValueOfLiabilities
35000000.0
CY2020Q2 scyx Fair Value Of Liabilities
FairValueOfLiabilities
51200000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
830343
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.52
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
96000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
797050
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
20313
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.72
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1607080
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.70
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
576904
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
26.62
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
18000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1607080
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
14.70
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
175000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
CY2021Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
542000

Files In Submission

Name View Source Status
0001564590-21-044448-index-headers.html Edgar Link pending
0001564590-21-044448-index.html Edgar Link pending
0001564590-21-044448.txt Edgar Link pending
0001564590-21-044448-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20210630.htm Edgar Link pending
scyx-10q_20210630_htm.xml Edgar Link completed
scyx-20210630.xsd Edgar Link pending
scyx-20210630_cal.xml Edgar Link unprocessable
scyx-20210630_def.xml Edgar Link unprocessable
scyx-20210630_lab.xml Edgar Link unprocessable
scyx-20210630_pre.xml Edgar Link unprocessable
scyx-ex101_47.htm Edgar Link pending
scyx-ex102_65.htm Edgar Link pending
scyx-ex311_10.htm Edgar Link pending
scyx-ex312_6.htm Edgar Link pending
scyx-ex321_8.htm Edgar Link pending
Show.js Edgar Link pending